Tania Payo-Serafín

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Randomized Controlled Trial

Systematic Review

Top Venues

Clinical pharmacology and therapeutics

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Tania Payo-Serafín, Carolina Méndez-Blanco, Paula Fernández-Palanca, Jennifer Martínez-Geijo, María Reviejo, Juan José Ortiz-de-Urbina, Javier Gonzalez-Gallego, Jose J G Marin, José Luis Mauriz, Beatriz San-Miguel
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical pharmacology and therapeutics 116 (2) (2024)
Tania Payo-Serafín, Carolina Méndez-Blanco, Paula Fernández-Palanca, Jennifer Martínez-Geijo, María Reviejo, Juan José Ortiz-de-Urbina, Javier Gonzalez-Gallego, Jose J G Marin, José Luis Mauriz, Beatriz San-Miguel
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical pharmacology and therapeutics (2024)
Paula Fernández-Palanca, Tania Payo-Serafín, Flavia Fondevila, Carolina Méndez-Blanco, Beatriz San-Miguel, Marta R Romero, María Jesús Tuñón, Jose J G Marin, Javier Gonzalez-Gallego, José Luis Mauriz
Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies. Cancers 14 (14) (2022)
Flavia Fondevila, Paula Fernández-Palanca, Carolina Méndez-Blanco, Tania Payo-Serafín, Elisa Lozano, Jose J G Marin, Javier Gonzalez-Gallego, José Luis Mauriz
Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers 13 (21) (2021)
Flavia Fondevila, Carolina Méndez-Blanco, Paula Fernández-Palanca, Tania Payo-Serafín, Jos van Pelt, Chris Verslype, Javier Gonzalez-Gallego, José Luis Mauriz
Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib. International journal of molecular sciences 22 (21) (2021)